Bluyssen HAR - Search Results

1

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.

Kluzek K, Srebniak MI, Majer W, Ida A, Milecki T, Huminska K, van der Helm RM, Silesian A, Wrzesinski TM, Wojciechowicz J, Beverloo BH, Kwias Z, Bluyssen HAR, Wesoly J. Kluzek K, et al. Among authors: bluyssen har. Oncotarget. 2017 Apr 25;8(17):28558-28574. doi: 10.18632/oncotarget.15331. Oncotarget. 2017. PMID: 28212566 Free PMC article.

2

The epigenetic landscape of clear-cell renal cell carcinoma.

Kluzek K, Bluyssen HA, Wesoly J. Kluzek K, et al. J Kidney Cancer VHL. 2015 May 28;2(3):90-104. doi: 10.15586/jkcvhl.2015.33. eCollection 2015. J Kidney Cancer VHL. 2015. PMID: 28326264 Free PMC article.

3

FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data.

Zodro E, Jaroszewski M, Ida A, Wrzesiński T, Kwias Z, Bluyssen H, Wesoly J. Zodro E, et al. Tumour Biol. 2014 Mar;35(3):2607-17. doi: 10.1007/s13277-013-1344-4. Epub 2013 Dec 8. Tumour Biol. 2014. PMID: 24318988 Free PMC article.

4

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma.

Majer W, Kluzek K, Bluyssen H, Wesoły J. Majer W, et al. J Cancer. 2015 Sep 5;6(11):1105-13. doi: 10.7150/jca.12145. eCollection 2015. J Cancer. 2015. PMID: 26516358 Free PMC article. Review.

5

Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications.

Rydzanicz M, Wrzesiński T, Bluyssen HA, Wesoły J. Rydzanicz M, et al. Cancer Lett. 2013 Dec 1;341(2):111-26. doi: 10.1016/j.canlet.2013.08.006. Epub 2013 Aug 7. Cancer Lett. 2013. PMID: 23933176 Review.

6

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.

Wrzesiński T, Szelag M, Cieślikowski WA, Ida A, Giles R, Zodro E, Szumska J, Poźniak J, Kwias Z, Bluyssen HA, Wesoly J. Wrzesiński T, et al. BMC Cancer. 2015 Jul 14;15:518. doi: 10.1186/s12885-015-1530-4. BMC Cancer. 2015. PMID: 26169495 Free PMC article.

7

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.

Szelag M, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HA. Szelag M, et al. Oncotarget. 2016 Jul 26;7(30):48788-48812. doi: 10.18632/oncotarget.9195. Oncotarget. 2016. PMID: 27166190 Free PMC article. Review.

8

Identification of RCC Subtype-Specific microRNAs-Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data.

Kajdasz A, Majer W, Kluzek K, Sobkowiak J, Milecki T, Derebecka N, Kwias Z, Bluyssen HAR, Wesoly J. Kajdasz A, et al. Among authors: bluyssen har. Cancers (Basel). 2021 Feb 1;13(3):548. doi: 10.3390/cancers13030548. Cancers (Basel). 2021. PMID: 33535553 Free PMC article.

9

Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.

Pstrąg N, Ziemnicka K, Bluyssen H, Wesoły J. Pstrąg N, et al. Mol Cancer. 2018 Aug 8;17(1):116. doi: 10.1186/s12943-018-0866-1. Mol Cancer. 2018. PMID: 30089490 Free PMC article. Review.

10

Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.

Sikorski K, Wesoly J, Bluyssen HA. Sikorski K, et al. Int J Mol Sci. 2014 Aug 18;15(8):14313-31. doi: 10.3390/ijms150814313. Int J Mol Sci. 2014. PMID: 25196434 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters